Overview of Vitiligo Research April - June 2014
- The first part of review series on vitiligo dedicated to disease pathogenesis and triggers recently published.
- Epidemiological study found no gender differences in vitiligo. Consanguinity in marriage increases incidence in vitiligo.
- Candidate biomarkers confirm the autoimmune nature of vitiligo progression.
- Several previous studies pointed to the superior efficiency of high-intensity narrow-band ultraviolet (NB-UVB) over conventional NB-UVB phototherapy.
- Anti-oxidant effect of NB-UVB in vitiligo patients unexpectedly found, witnessed by a decrease in initially elevated markers of oxidative stress.
- An Eastern medicine treatment, moxibution, reported with good clinical results accompanied by normalization of altered immunological parameters in vitiligo patients.
This is our quarterly review of research results in the vitiligo field which were indexed in the PubMed database (www.ncbi.nlm.nih.gov/pubmed) for the period from April 2014 till June 2014. Abstracts of papers were retrieved from the PubMed database using the search term “vitiligo” with a filter set up to retrieve records with creation date between April 01, 2014 and June 30, 2014. Retrieved records were manually checked for a relevance to and significance for the field of vitiligo research. Thirty six records were found to be relevant and of interest, and were included into this quarterly overview.
Join Us for the Master Class
Our next Master Class on Vitiligo and Pigmentary Disorders in Turkey will offer colleagues from across the world an ideal environment to learn about recent advances, future developments and prospective research opportunities, and to exchange ideas and experiences in the field of pigmentary disorders.
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
NY Vitiligo Community Meeting in September
Our next meeting will be on Thursday, September 21st, at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Av...21 September 2017 19:00, 11th floor of NYU's Ambulatory Car...
Vitiligo Advocacy Day at the US Capitol
Save-the-Date for the much anticipated Vitiligo Advocacy Day at the United States Capitol this fall. As many of you know, the Advocacy Committee of the Global Vitilig...04 October 2017 10:00, Washington, DC
Why there is no drug for vitiligo yet?
Despite the dearth of medications available to treat psoriasis - a disease with similar prevalence numbers and impact on quality of life - vitiligo has no known cure o...
I have vitiligo: will my children have vitiligo, too?
In some cases vitiligo seems to be inherited and run in families, with children whose parents have vitiligo being at increased risk of developing the condition themsel...
Isn't it just a cosmetic disorder?
Like it or not, we live in a society where appearance matters. It should come as no surprise that vitiligo impacts on the psychological well-being and quality of life ...
How long does it take to treat vitiligo?
Treatment results will vary by person and type of vitiligo. The rule of thumb is that you will need to allow at least 3 to 6 months before you begin to see results fro...